Saline Solution Basi 9 mg/ml solution for infusion, Felzartamab
299AR301
Phase 3 small_molecule active
Quick answer
Saline Solution Basi 9 mg/ml solution for infusion, Felzartamab for Kidney Transplant Recipients with Late Antibody-Mediated Rejection is a Phase 3 program (small_molecule) at Biogen Idec Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biogen Idec Ltd
- Indication
- Kidney Transplant Recipients with Late Antibody-Mediated Rejection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active